7.2.2.13	1-chloro-2,4-dinitrobenzene	increase of the hydrolytic activity of the Na/K ATPase	671274	
7.2.2.13	4-aminobutyric acid	hypothesis: stimulate Na+/K+ transport via specific receptor inputs	672864	
7.2.2.13	8-pCPT-CGMP	induces a concentration-dependent increase in pump current, activator of PKG	675720	
7.2.2.13	aldosterone	control of Na,K-ATPase activity and expression	677134	
7.2.2.13	Baclofen	hypothesis: stimulate Na+/K+ transport via specific receptor inputs	672864	
7.2.2.13	beta-catenin	expression of beta-catenin significantly enhances the ouabain-sensitive current of the endogeneous Na+/K+-ATPase. beta-Catenin does not significantly modify the retrieval of the Na+/K+ ATPase from the cell membrane. The stimulating effect of beta-catenin on both Na+/K+ ATPase and Na+-coupled glucose transporter SGLT1 activity is observed even in the presence of actinomycin D	718740	
7.2.2.13	dephostatin	-	675517	
7.2.2.13	desipramine	inhibitor of adrenalin uptake and antidepressive action. Treatment differentially enhances the activity of Na+K+-ATPase alpha isoforms	688762	
7.2.2.13	dexamethasone	postnatal treatment of lamb with 0.5 mg per kg results in 21.4% increase in Na+K+-ATPase activity and a 30.4% increase in catalytic subunit alpha1 expression in the cerebral cortex. Treatment is not associated with significant changes in subunit beta1 expression. In the kidney, dexamethasone treatment is not associated with significant changes in enzyme activity, or alpha-1- or beta-1-isoform expression	690001	
7.2.2.13	epinephrine	hypothesis: stimulate Na+/K+ transport via specific receptor inputs	672864